Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126645902 | 12664590 | 2 | F | 201606 | 20160824 | 20160818 | 20160831 | EXP | FR-AFSSAPS-RN20161286 | FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-53046FF | BOEHRINGER INGELHEIM | 78.01 | YR | M | Y | 0.00000 | 20160831 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126645902 | 12664590 | 1 | PS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 5 MCG | 21936 | 5 | UG | PRESSURISED INHALATION | QD | ||||||
| 126645902 | 12664590 | 2 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG | 0 | 10 | MG | COATED TABLET | QD | ||||||
| 126645902 | 12664590 | 3 | SS | PREVISCAN | FLUINDIONE | 1 | Oral | DOSE PER APPLICATION AND DAILY DOSE: 15MG EVERY OVER DAY ALTERNATING WITH 20MG EVERY OTHER DAY | 0 | TABLET | QOD | ||||||||
| 126645902 | 12664590 | 4 | SS | GABAPENTINE | GABAPENTIN | 1 | Oral | 900 MG | 0 | 300 | MG | TID | |||||||
| 126645902 | 12664590 | 5 | SS | TRIATEC | RAMIPRIL | 1 | Oral | 5 MG | 0 | 2.5 | MG | TABLET | BID | ||||||
| 126645902 | 12664590 | 6 | SS | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 3 G | 0 | 1 | G | TID | |||||||
| 126645902 | 12664590 | 7 | SS | DIGOXINE NATIVELLE | DIGOXIN | 1 | Oral | 0.25 MG | 0 | .25 | MG | TABLET | QD | ||||||
| 126645902 | 12664590 | 8 | SS | BISOPROLOL | BISOPROLOL | 1 | Oral | 5 MG | 0 | 5 | MG | TABLET | QD | ||||||
| 126645902 | 12664590 | 9 | SS | REPAGLINIDE. | REPAGLINIDE | 1 | Oral | 1 MG | 0 | .5 | MG | BID | |||||||
| 126645902 | 12664590 | 10 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG | 0 | 100 | MG | QD | |||||||
| 126645902 | 12664590 | 11 | SS | AERIUS | DESLORATADINE | 1 | Oral | 10 MG | 0 | 5 | MG | ||||||||
| 126645902 | 12664590 | 12 | SS | FLUTIFORM | FLUTICASONE PROPIONATEFORMOTEROL FUMARATE | 1 | Respiratory (inhalation) | 4 ANZ | 0 | ORAL SUSPENSION | BID | ||||||||
| 126645902 | 12664590 | 13 | SS | VENTOLINE | ALBUTEROL | 1 | Respiratory (inhalation) | DAILY DOSE: 100MG PER INHALATION | 0 | 100 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126645902 | 12664590 | 1 | Asthma |
| 126645902 | 12664590 | 2 | Hypercholesterolaemia |
| 126645902 | 12664590 | 3 | Thrombosis prophylaxis |
| 126645902 | 12664590 | 4 | Product used for unknown indication |
| 126645902 | 12664590 | 5 | Hypertension |
| 126645902 | 12664590 | 6 | Pain |
| 126645902 | 12664590 | 7 | Atrial fibrillation |
| 126645902 | 12664590 | 8 | Hypertension |
| 126645902 | 12664590 | 9 | Type 2 diabetes mellitus |
| 126645902 | 12664590 | 10 | Hyperuricaemia |
| 126645902 | 12664590 | 11 | Product used for unknown indication |
| 126645902 | 12664590 | 12 | Asthma |
| 126645902 | 12664590 | 13 | Asthmatic crisis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126645902 | 12664590 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126645902 | 12664590 | Eosinophilia | |
| 126645902 | 12664590 | Lung disorder | |
| 126645902 | 12664590 | Pleural effusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |